On the other hand, metabolic (non-alcoholic) fatty liver disease (MAFLD), characterized by hepatic triglyceride accumulation unrelated to excess alcohol consumption, is associated with increased visceral adipose tissue (VAT), IR, dyslipidemia and reduced SHBG levels [124,125,146]. Here, SHBG is linked to metabolic syndrome.